Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, Exhibit opportunities are also available, however, space is limited.


2017–18 New York Lymphoma Rounds Series – TBA

About the Program
The Lymphoma Research Foundation's New York Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the New York City area.


At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

Additional Information
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

New York Lymphoma Rounds Steering Committee

Columbia University Medical Center
Owen O'Connor, MD, PhD
Hackensack University Medical Center
Andre Goy, MD, MS
Icahn School of Medicine at Mount Sinai
Josh Brody, MD
Akshay Sudhindra, MD
Memorial Sloan Kettering Cancer Center
David Straus, MD (chair)
NYU Langone Medical Center
Catherine Diefenbach, MD
Rutgers Cancer Institute of New Jersey
Joseph Bertino, MD
Weill Cornell Medical Center
Koen van Besien, MD
Ethel Cesarman, MD, PhD
Amy Chadburn, MD
Morton Coleman, MD


This activity is supported by educational grants from:

AbbVie, Bristol-Myers Squibb, Celgene, Genentech, Kite Pharma, Seattle Genetics, Spectrum Pharmaceuticals, Teva Pharmaceuticals Industries, LTD
and TG Therapeutics

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.